ALIGNMENT HEALTHCARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.000 USD | -4.36% |
|
-8.26% | +4.53% |
| 08-16 | Alignment Healthcare, Inc. Announces Board and Committee Changes | CI |
| 08-02 | UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating | MT |
Company Valuation: Alignment Healthcare, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,633 | 2,202 | 1,628 | 1,800 | - | - |
| Change | - | -16.35% | -26.07% | 10.56% | - | - |
| Enterprise Value (EV) 1 | 2,317 | 1,954 | 1,587 | 1,728 | 1,688 | 1,648 |
| Change | - | -15.67% | -18.76% | 8.9% | -2.33% | -2.39% |
| P/E ratio | -12.3x | -14.2x | -10.9x | -14x | -18.3x | -23.1x |
| PBR | - | 9.25x | 10.2x | 17.2x | 19.5x | 17.4x |
| PEG | 0.1x | 0.5x | 2.26x | 0.9x | 0.8x | 1.1x |
| Capitalization / Revenue | 2.25x | 1.54x | 0.89x | 0.68x | 0.55x | 0.45x |
| EV / Revenue | 1.98x | 1.36x | 0.87x | 0.66x | 0.51x | 0.42x |
| EV / EBITDA | -70x | -73.1x | -44.9x | -5,079x | 41.7x | 21.5x |
| EV / EBIT | -47.1x | -44.2x | -27.8x | -69.8x | 167x | 33.9x |
| EV / FCF | - | -28.2x | -16.7x | -61.8x | 57.5x | 31.2x |
| FCF Yield | - | -3.54% | -6% | -1.62% | 1.74% | 3.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.14 | -0.83 | -0.79 | -0.6715 | -0.5134 | -0.4067 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1,168 | 1,434 | 1,824 | 2,631 | 3,289 | 3,960 |
| EBITDA 1 | -33.12 | -26.72 | -35.32 | -0.3403 | 40.45 | 76.6 |
| EBIT 1 | -49.15 | -44.2 | -56.99 | -24.74 | 10.08 | 48.58 |
| Net income 1 | -195.3 | -149.5 | -148 | -127.8 | -96.57 | -79.67 |
| Net Debt 1 | -316 | -248.6 | -41.09 | -71.83 | -112.1 | -152.4 |
| Reference price 2 | 14.060 | 11.760 | 8.610 | 9.410 | 9.410 | 9.410 |
| Nbr of stocks (in thousands) | 187,242 | 187,261 | 189,100 | 191,300 | - | - |
| Announcement Date | 03/03/22 | 28/02/23 | 27/02/24 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E ratio | EV / Sales | EV / EBITDA | Yield (Y) | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -14.01x | 0.66x | -5078.9x | -.--% | 1.8B | ||
| 36.6x | 1.48x | 15.25x | +1.34% | 549B | ||
| 15.69x | 0.84x | 11.04x | +1.16% | 126B | ||
| 19.96x | 0.52x | 9.11x | +1.56% | 99.97B | ||
| 24.41x | 0.4x | 11.78x | +1.05% | 41.39B | ||
| 11.91x | 0.25x | 8.98x | -.--% | 37.26B | ||
| 15.08x | 0.39x | 7.8x | -.--% | 18.97B | ||
| 38.83x | 1.6x | 9.24x | -.--% | 2.13B | ||
| -17.93x | - | - | -.--% | 1.25B | ||
| Average | 14.50x | 0.77x | -625.71x | +0.57% | 97.49B | |
| Weighted average by Cap. | 29.43x | 1.15x | 2.87x | +1.23% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ALHC Stock
- Valuation Alignment Healthcare, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition